BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ogawa E, Yeo YH, Dang N, Le MH, Jeong D, Tran S, Henry L, Cheung R, Nguyen MH. Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States. JAMA Netw Open 2020;3:e201844. [PMID: 32271388 DOI: 10.1001/jamanetworkopen.2020.1844] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Kam LY, Huang DQ, Tobias AF, Poon K, Henry L, Kwo P, Cheung R, Nguyen MH. Impact of advanced practice providers on characteristics and quality of care of patients with chronic hepatitis B. Aliment Pharmacol Ther 2022. [PMID: 36266768 DOI: 10.1111/apt.17254] [Reference Citation Analysis]
2 Wong RJ, Kaufman HW, Niles JK, Meyer WA 3rd, Chitnis AS. Prevalence of Hepatitis B Virus and Latent Tuberculosis Coinfection in the United States. J Public Health Manag Pract 2022;28:452-62. [PMID: 35867500 DOI: 10.1097/PHH.0000000000001536] [Reference Citation Analysis]
3 Reveron-Thornton RF, Teng MLP, Lee EY, Tran A, Vajanaphanich S, Tan EX, Nerurkar SN, Ng RX, Teh R, Tripathy DP, Ito T, Tanaka T, Miyake N, Zou B, Wong C, Toyoda H, Esquivel CO, Bonham CA, Nguyen MH, Huang DQ. Global and regional long-term survival following resection for HCC in the recent decade: A meta-analysis of 110 studies. Hepatol Commun 2022. [PMID: 35234371 DOI: 10.1002/hep4.1923] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Ramrakhiani NS, Chen VL, Le M, Yeo YH, Barnett SD, Waljee AK, Zhu J, Nguyen MH. Optimizing hepatitis B virus screening in the United States using a simple demographics-based model. Hepatology 2022;75:430-7. [PMID: 34496066 DOI: 10.1002/hep.32142] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Wong RJ, Cheung RC. Real-World Safety and Effectiveness of Oral Nucleos(t)ide Analogs in the Treatment of Chronic Hepatitis B Virus Infection. Curr Hepatology Rep 2021;20:144-150. [DOI: 10.1007/s11901-021-00571-z] [Reference Citation Analysis]
6 Hubbard A, Hirode G, Chitnis A, Wong R. Prevalence of hepatitis B surface antigen and hepatitis B core antibody among adults with latent tuberculosis infection. European Journal of Gastroenterology & Hepatology 2021;33:e610-e614. [DOI: 10.1097/meg.0000000000002180] [Reference Citation Analysis]
7 Hsu YC, Tseng CH, Nguyen MH. Reply. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01139-3. [PMID: 34678514 DOI: 10.1016/j.cgh.2021.10.026] [Reference Citation Analysis]
8 Ju YC, Jun DW, Yoon EL, Ahn SB, Kim YJ, Nguyen MH. Nationwide Data on the Characteristics of Linked-to-Care Chronic Hepatitis B in Korea. J Clin Med 2021;10:4633. [PMID: 34682760 DOI: 10.3390/jcm10204633] [Reference Citation Analysis]
9 Ye Q, Kam LY, Yeo YH, Dang N, Huang DQ, Cheung R, Nguyen MH. Substantial gaps in evaluation and treatment of patients with hepatitis B in the US. J Hepatol 2021:S0168-8278(21)02014-6. [PMID: 34474097 DOI: 10.1016/j.jhep.2021.08.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Huang DQ, Hoang JK, Nguyen MH. HBV-related hepatocellular carcinoma: A call to improve surveillance and linkage to care. Liver Int 2021;41:2238-9. [PMID: 34309185 DOI: 10.1111/liv.15023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Wong RJ, Brosgart CL, Welch S, Block T, Chen M, Cohen C, Kim WR, Kowdley KV, Lok AS, Tsai N, Ward J, Wong SS, Gish RG. An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States. Hepatology 2021;74:607-26. [PMID: 33655536 DOI: 10.1002/hep.31782] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 19.0] [Reference Citation Analysis]
12 Chitnis AS, Cheung R, Gish RG, Wong RJ. Epidemiology and Prevention of Tuberculosis and Chronic Hepatitis B Virus Infection in the United States. J Immigr Minor Health 2021. [PMID: 34160726 DOI: 10.1007/s10903-021-01231-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Hu J, Wang Y, Jiang G, Zheng J, Chen T, Chen Z, Yang M, Zhang X, Zhao H, Li L. Predictors of inflammatory activity in treatment-naive hepatitis B e-antigen-negative patients with chronic hepatitis B infection. J Int Med Res 2020;48:300060520969582. [PMID: 33179557 DOI: 10.1177/0300060520969582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Toy M, Hutton D, Harris AM, Nelson N, Salomon JA, So S. Cost-Effectiveness of One-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States. Clin Infect Dis 2021:ciab405. [PMID: 33956937 DOI: 10.1093/cid/ciab405] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
15 Jones PD, Gmunder K, Batrony S, Martin P, Kobetz E, Carrasquillo O. Acceptability and Feasibility of Home-Based Hepatitis B Screening Among Haitian Immigrants. J Immigr Minor Health 2021;23:1170-8. [PMID: 33686574 DOI: 10.1007/s10903-021-01165-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Huang DQ, Nguyen MH. Treatment eligibility in hepatitis B: a call for better linkage to optimal care. The Lancet Gastroenterology & Hepatology 2021;6:160. [DOI: 10.1016/s2468-1253(20)30391-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Ji F, Li T, Nguyen MH. Improved survival and high sustained virologic response with DAA therapy in patients with HCV-related HCC: A call for expanded use. J Gastroenterol Hepatol 2021;36:1721-2. [PMID: 33528034 DOI: 10.1111/jgh.15420] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Ye Q, Kam LY, Yeo YH, Dang N, Huang DQ, Cheung R, Nguyen M. Substantial Gaps in Evaluation and Treatment of Hepatitis B Patients in the US: A Nationwide Study of 14,693 Patients. SSRN Journal. [DOI: 10.2139/ssrn.3759709] [Reference Citation Analysis]
19 Ji F, Li J, Liu L, Liang J, Wang X, Liu J, Cai D, Huang R, Zhang J, Wang Q, Nan Y, Li J, Ye Q, Zhang M, Xu Q, Guo F, Zhao C, Liu L, He C, Li Y, Wang W, Kam LY, Tran S, Maeda M, Mizuta A, Li Z, Dang S, Ren W, Zhu Q, Cheung R, Niu J, Xie W, Pan H, Ren H, Wu C, Shang J, Wang F, Nguyen MH. High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b. J Gastroenterol Hepatol 2021;36:767-74. [PMID: 32840326 DOI: 10.1111/jgh.15192] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
20 Toyoda H, Huang DQ, Le MH, Nguyen MH. Liver Care and Surveillance: The Global Impact of the COVID-19 Pandemic. Hepatol Commun. 2020;4:1751-1757. [PMID: 32838107 DOI: 10.1002/hep4.1579] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]